Aquilo Capital Management »

Merus N V shares owned by Aquilo Capital Management

Quarter-by-quarter ownership of Merus N V (MRUS) shares owned by Aquilo Capital Management from 13F filings

Historical chart of Aquilo Capital Management investment in Merus N V

Tip: Access up to 7 years of quarterly data

All positions including Merus N V held by Aquilo Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Merus N V by Aquilo Capital Management

Quarter filed Position value Share count Share price at filing
2018-09-30 $26M 1.3M 19.74
2018-06-30 $29M 1.3M 22.76

More positions owned by Aquilo Capital Management

SPDR S&P Biotech (XBI)
Merus N V (MRUS)
Loxo Oncology
Fate Therapeutics (FATE)
Aduro Biotech
Synlogic
Cytomx Therapeutics (CTMX)
Pieris Pharmaceuticals
Spero Therapeutics (SPRO)
Xenon Pharmaceuticals (XENE)
Galapagos Nv- (GLPG)
Morphosys (MOR)

View all positions for Aquilo Capital Management

Top funds holding Merus N V

Paradigm Biocapital Advisors
venBio Select Advisor
Commodore Capital
Deerfield Management Company
FMR
BlackRock
Westfield Capital Management Company
Rtw Investments
Woodline Partners
Glazer Capital
Goldman Sachs Group
Lynx1 Capital Management
Perceptive Advisors
Federated Investors
Alliancebernstein

View all funds holding Merus N V